Sergey A. Dzugan, M.D., Ph.D

Sergey A. Dzugan M.D., Ph.D is an internationally known expert in anti-aging and hormonal medicine. He has 127 publications in surgical, oncology, academic and anti-aging medical journals, and holds three patents in the area of cardiovascular surgery. He has been invited to speak at numerous anti-aging conferences with presentations including “A New Method of Migraine Treatment: The Simultaneous Restoration of Neurohormonal and Metabolic Integrity.”

Dr. Dzugan graduated from the Donetsk State Medical Institute with a Doctorate of Medicine in August, 1979. After medical school, he performed his residency in general and cardiovascular surgery and became the Head of Heart Services in 1985. In 1990, he received his Ph. D. in Medical Science concerning heart rhythm disorder and subsequently became Assistant Professor at the Donetsk State Medical Institute.

In May of 1991, he became the first Chief of the Department of Cardiovascular Surgery and Senior Heart Surgeon, in Donetsk District Regional Hospital, Ukraine. His department serviced not only the 1.1 million people in the city of Donetsk, but an additional surrounding population of 5.5 million. In March of 1993, he became Associate Professor at Donetsk State Medical University. Dr. Dzugan performed a wide specter of operations for children and adults, including congenital and acquired heart diseases, and rhythm disorders.

As a practicing physician, Dr. Dzugan always found himself more in favor of holistic and natural medicines rather than synthetic. He always believed that strengthening ones immune system would do more to improve their health than treating problems after they occur. Because of this, while performing heart surgeries, Dr. Dzugan became more interested in the preventive aspect of heart disease and began studying hormone treatments.

In 1996, upon moving to the United States, Dr. Dzugan became a scientific consultant to Dr. Arnold Smith at the North Central Mississippi Regional Cancer Center in Greenwood, Mississippi for 7 years. His role there was to stay current on the latest advances in nutraceutical treatments with a particular focus on such to improve immunity and the ability of patients to fight cancer*. He has become board certified by the American Board of Anti-Aging Medicine. His employers at the North Central Regional Center have expressed that they believe he "is extremely valuable to patient care and his role differentiates the North Central Mississippi Regional Cancer Center from that of any other center in the state, because no other center has a full time well qualified staff person to meet the same function."

His patients commend him for his patience and ability to explain their problems without the use of jargon, much the way a teacher, rather than a doctor, would speak. This ability allows Dr. Dzugan to establish an extremely close relationship with his patients, and he stresses this in everyone he trains. Dr. Smith and his other employers laud him for the countless hours he puts in to his job as he continuously thinks of better ways to treat his patients both in and out of the office. In 2001, Dr. Dzugan suggested a new hypothesis of hypercholesterolemia and developed a new statin free method of high cholesterol treatment. He also developed a unique multimodal program for migraine management.

In 2003 he moved to Ft. Lauderdale, Florida, and became the Manager of the Advisory Department at the Life Extension Foundation. Later, he became President of Life Extension Scientific Information Inc. He has been invited to speak at several anti-aging conferences with presentations including Hypercholesterolemia Treatment: "A New Hypothesis or Just an Accident?", "Hypercholesterolemia Treatment: a New Statin Free Method" and "A New Method of Migraine Treatment: The Simultaneous Restoration of Neurohormonal and Metabolic Integrity."

In late 2006, Dr. Dzugan left the Life Extensions Foundation to create the Migraine Program, a scientific organization that consults with physicians to develop the optimal plans for their patients to prevent migraine.

George W. Rozakis M.D.

George W. Rozakis M.D. is a pioneering Lasik eye surgeon. Four years ago he became interested in the field of antiaging medicine upon meeting a doctor in Hawaii who was implementing this type of care to his patients. Encouraged by what he heard he attended a conference in Chicago on antiaging medicine and found it to be a highly fragmented area without clear direction. Sensing that this was similar to the early days of Lasik he decided to return to these conferences and identify the most capable thinker in the field of antiaging medicine. Serendipitously, this led to his meeting Dr. Sergey Dzugan M.D. Ph.D.

Dr. Dzugan trained Dr. Rozakis in antiaging medicine and assisted him in the delivery of such care to many of his Lasik patients who experienced a profound improvement in their quality-of-life as well as lower levels of cholesterol, less fatigue and other important improvements. Over the course of two years it became completely clear to Dr. Rozakis that type of care involving vitamins, supplements and bioidentical hormones held great promise to reverse the symptoms of aging.

Upon finding his first severe case of migraine headache, Dr. Rozakis implemented Dr. Dzugan's methods for migraine prevention. This first case had migraine headache since the age of five. She met Dr. Rozakis at the age of 37 at which point in her life she had seen virtually every headache clinic in the Cleveland area and had tried every remedy known to conventional medicine as well as a few alternative strategies. With the help of Dr. Dzugan this patient is currently doing exceedingly well and has gotten her life back. She was recently interviewed by Cleveland's Fox eight as a testimonial to Dr. Dzugan's science. To meet Dr. Rozakis on this television program, click here. Dr. Rozakis and Dr. Dzugan are now working together to help deliver this extraordinary care to patients worldwide through the use of the Internet and through forward thinking medical practitioners.

Dr. Rozakis is also developing strategies to use antiaging medicine to prevent macular degeneration. As he and Dr. Dzugan predicted, recent studies in the American Journal of Ophthalmology have shown that patients who develop macular degeneration have profoundly subnormal levels of hormones. Together with Dr. Dzugan they are developing strategies to reverse these deficiencies in the attempt to halt this devastating cause of blindness.

 

*The Migraine Program is not intended to treat cancer patients.